Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

PTHS stock hub

Pelthos Therapeutics Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

PTHSis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

85.5M

NYSEAMERICAN

Market data

Live price

Current market quote for this ticker.

Current price

PTHS

In the news

Latest news · PTHS

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-239.5

P25 -105.6P50 -46.5P75 -3.1

ROIC-53.6

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All PTHS market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

186

Groups with data

Currency

USD

Showing 186 of 186 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001919246
Company name	Pelthos Therapeutics Inc.
Country	United States
Country code	US
Employees	92
Employees Change	81%
Employees Change Percent	736.4
Enterprise value	$102.4M
Exchange	NYSEAMERICAN
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US1711262048
Last refreshed	2026-05-10
Market cap	$85.5M
Market cap category	Micro-Cap
Price	$25.5
Price currency	USD
Rev Per Employee	182,554.35x
Sector	Healthcare
Sic	2836
Symbol	PTHS
Website	https://pelthos.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-50.64%
EV Sales Forward	1.65x
EV/Sales	6.1x
FCF yield	-26.52%
P/B ratio	2.12x
P/S ratio	5.09x
PS Forward	1.38x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-187.01%
EBITDA Margin	-173.4%
Gross margin	68.94%
Gross Profit	$11.6M
Net Income	$-43.3M
Net Income Growth Years	0%
Pretax Margin	-301.91%
Profit Margin	-257.93%
Profit Per Employee	$-470,859
ROA	-29.8
ROCE	-30.08
ROE	-239.5
ROIC	-53.65

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	134.04%
EPS Growth Years	0
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.25
Assets	$130.4M
Cash	$18M
Current Assets	$53.4M
Current Liabilities	$26M
Debt	$34.8M
Debt Equity	$0.9
Equity	$38.9M
Interest Coverage	-10.43
Liabilities	$91.5M
Long Term Assets	$77M
Long Term Liabilities	$65.5M
Net Cash	$-16.9M
Net Cash By Market Cap	$-19.7
Net Debt Equity	$0.43
Tangible Book Value	$-25.3M
Tangible Book Value Per Share	$-7.81
WACC	18.02

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.05
Net Working Capital	$10.1M
Quick ratio	1.03
Working Capital	$27.4M
Working Capital Turnover	$1.36

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-237.34%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	133.9%
200-day SMA	25.79
50-day SMA	23.38
50-day SMA vs 200-day SMA	50under200
All Time High	60
All Time High Change	-57.51%
All Time High Date	2024-02-16
All Time Low	4.5
All Time Low Change	466.56%
All Time Low Date	2024-11-19
ATR	1.02
Beta	3.33
Beta1y	1.71
Beta2y	1.7
Ch YTD	-17.76
High	25.67
High52	54.29
High52 Date	2025-07-07
High52ch	-53.04%
Low	24.63
Low52	9
Low52 Date	2025-06-02
Low52ch	183.28%
Ma50ch	9.04%
Price vs 200-day SMA	-1.15%
RSI	63.53
RSI Monthly	46.51
RSI Weekly	52.77
Sharpe ratio	1.14x
Sortino ratio	2.27
Total Return	-237.34%
Tr YTD	-17.76
Tr1m	12.12%
Tr1w	1.98%
Tr3m	10.9%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	6
Analyst Count Top	1
Analyst Price Target Top	$48
Analyst Ratings	Strong Buy
Analyst Ratings Top	Buy
Earnings EPS Estimate	$-3.66
Earnings Revenue Estimate	10,303,888x
Operating Income	$-31.4M
Operating margin	-187
Price target	$54.17
Price Target Change	$112
Price Target Change Top	$88.27

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,345,991%
Float Percent	40.11%
Net Borrowing	17,746,000
Shares Insiders	7.56%
Shares Institutions	28.69%
Shares Out	3,355,543
Shares Qo Q	3.04%
Shares Yo Y	237.34%
Short Float	3.41%
Short Ratio	4.66
Short Shares	1.37

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-28.2M
Average Volume	17,431.6x
Bv Per Share	12.02
CAPEX	$-99,000
Ch1m	12.12
Ch1w	1.98
Ch1y	133.9
Ch3m	10.9
Ch6m	-25.89
Change	1.86%
Change From Open	1.29
Close	25.03
Days Gap	0.56
Depreciation Amortization	2,285,000
Dollar Volume	367,128
Earnings Date	2026-05-14
Earnings Time	bmo
EBIT	$-31.4M
EBITDA	$-29.1M
EPS	$-23.04
F Score	2
FCF	$-22.7M
FCF EV Yield	-22.16x
FCF Per Share	$-6.76
Financing CF	45,336,000
Fiscal Year End	December
Founded	2,002
Goodwill	24,681,000
Income Tax	$-7.4M
Investing CF	-5,236,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-19
Last Report Date	2025-12-31
Last Split Date	2025-07-02
Last Split Type	Reverse
Last10k Filing Date	2026-03-19
Ma150	25.89
Ma150ch	-1.51%
Ma20	24.04
Ma20ch	6.04%
Net CF	17,510,000
Next Earnings Date	2026-05-14
Open	25.17
Optionable	No
Position In Range	83.17
Ppne	12,836,000
Price Date	2026-05-08
Relative Volume	0.83x
Revenue	16,795,000x
SBC By Revenue	32.52x
Share Based Comp	5,461,000
Tax By Revenue	-43.98x
Tr6m	-25.89%
Us State	North Carolina
Volume	14,400
Z Score	-0.85

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does PTHS pay a dividend?

Capital-return profile for this ticker.

Performance

PTHS stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns PTHS?

Insider, institutional, and short-interest positioning.

Institutional ownership

+28.7%

Float: +40.1% of shares outstanding

Insider ownership

+7.6%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

PTHS momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

63.5

Neutral momentum band

Price vs 200-day MA

-1.1%

50/200-day relationship not available

Beta (5Y)

3.33

More volatile than the market

Sharpe ratio

1.14

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About PTHS

Hub-level FAQ points readers to the deeper analysis pages.

What is the current PTHS stock rating?

Pelthos Therapeutics Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full PTHS analysis?

The full report lives at /stocks/PTHS/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for PTHS?

The latest report frames PTHS around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the PTHS page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.